Product Specifications
Studies have shown that 5-amino-1mq significantly reduces the insulin resistance index and decreases adipocyte size in aging mice, providing new intervention strategies for aging-related metabolic diseases such as type 2 diabetes and obesity
Actual dosing for any patient must be determined by a licensed medical provider based on individual health history, body composition goals, and concurrent treatments
This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only
Selective NNMT inhibitor (5-amino-1MQ) reduces adiposity in DIO mice
The majority of health insurance programs, such as Medicaid and Medicare Part B, will cover the cost of Vitamin B12 injections if they are deemed medically necessary by a healthcare professional, which includes treatment for conditions like pernicious anemia, malabsorption disorders, and following gastrectomy